Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Apollomics, Inc.

APLMWNASDAQ
Financial Services
Financial - Conglomerates
$0.01
$0.001(9.17%)
U.S. Market opens in NaNh NaNm

Apollomics, Inc. Fundamental Analysis

Apollomics, Inc. (APLMW) shows weak financial fundamentals with a PE ratio of -0.73, profit margin of -4.50%, and ROE of -133.85%. The company generates $92.9B in annual revenue with weak year-over-year growth of -1.00%.

Key Strengths

Cash Position14948.49%
PEG Ratio-0.02

Areas of Concern

ROE-133.85%
Operating Margin-3.96%
Current Ratio0.97
We analyze APLMW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -13813.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-13813.8/100

We analyze APLMW's fundamental strength across five key dimensions:

Efficiency Score

Weak

APLMW struggles to generate sufficient returns from assets.

ROA > 10%
-2.80%

Valuation Score

Excellent

APLMW trades at attractive valuation levels.

PE < 25
-0.73
PEG Ratio < 2
-0.02

Growth Score

Weak

APLMW faces weak or negative growth trends.

Revenue Growth > 5%
-1.00%
EPS Growth > 10%
-21.76%

Financial Health Score

Moderate

APLMW shows balanced financial health with some risks.

Debt/Equity < 1
-0.17
Current Ratio > 1
0.97

Profitability Score

Weak

APLMW struggles to sustain strong margins.

ROE > 15%
-13385.41%
Net Margin ≥ 15%
-4.50%
Positive Free Cash Flow
No

Key Financial Metrics

Is APLMW Expensive or Cheap?

P/E Ratio

APLMW trades at -0.73 times earnings. This suggests potential undervaluation.

-0.73

PEG Ratio

When adjusting for growth, APLMW's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Apollomics, Inc. at -5.17 times its book value. This may indicate undervaluation.

-5.17

EV/EBITDA

Enterprise value stands at -0.85 times EBITDA. This is generally considered low.

-0.85

How Well Does APLMW Make Money?

Net Profit Margin

For every $100 in sales, Apollomics, Inc. keeps $-4.50 as profit after all expenses.

-4.50%

Operating Margin

Core operations generate -3.96 in profit for every $100 in revenue, before interest and taxes.

-3.96%

ROE

Management delivers $-133.85 in profit for every $100 of shareholder equity.

-133.85%

ROA

Apollomics, Inc. generates $-2.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.80%

Following the Money - Real Cash Generation

Operating Cash Flow

Apollomics, Inc. generates limited operating cash flow of $-170.91B, signaling weaker underlying cash strength.

$-170.91B

Free Cash Flow

Apollomics, Inc. generates weak or negative free cash flow of $-170.91B, restricting financial flexibility.

$-170.91B

FCF Per Share

Each share generates $-11.56 in free cash annually.

$-11.56

FCF Yield

APLMW converts -56.11% of its market value into free cash.

-56.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.73

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

-5.17

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.28

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.17

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.97

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-133.85

vs 25 benchmark

ROA

Return on assets percentage

-2.80

vs 25 benchmark

ROCE

Return on capital employed

-42.40

vs 25 benchmark

How APLMW Stacks Against Its Sector Peers

MetricAPLMW ValueSector AveragePerformance
P/E Ratio-0.7319.28 Better (Cheaper)
ROE-13385.41%792.00% Weak
Net Margin-450.04%2238.00% Weak
Debt/Equity-0.170.85 Strong (Low Leverage)
Current Ratio0.97604.98 Weak Liquidity
ROA-280.49%-20889.00% (disorted) Weak

APLMW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Apollomics, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Value, Dividend, Cyclical

Declining

EPS CAGR

-9.91%

Industry Style: Value, Dividend, Cyclical

Declining

FCF CAGR

-22.72%

Industry Style: Value, Dividend, Cyclical

Declining

Fundamental Analysis FAQ